KLK3 and prostate carcinoma: Currently, accepted clinical methods to diagnose clinically significant prostate cancer (PCa) are a combination of the prostate-specific antigen (PSA) test, digital rectal exam, trans-rectal ultrasound (TRUS), and magnetic resonance imaging (MRI).